caffeine has been researched along with Demyelinating Diseases in 1 studies
Demyelinating Diseases: Diseases characterized by loss or dysfunction of myelin in the central or peripheral nervous system.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Caffeine, which is a competitive inhibitor of adenosine receptors, is commonly used as treatment for preterm apnoea in clinical settings." | 1.56 | Defining a Time Window for Neuroprotection and Glia Modulation by Caffeine After Neonatal Hypoxia-Ischaemia. ( Ådén, U; Blomgren, K; Bocchetta, E; Di Martino, E; Harris, RA; Mukai, T; Tsuji, S, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Di Martino, E | 1 |
| Bocchetta, E | 1 |
| Tsuji, S | 1 |
| Mukai, T | 1 |
| Harris, RA | 1 |
| Blomgren, K | 1 |
| Ådén, U | 1 |
1 other study available for caffeine and Demyelinating Diseases
| Article | Year |
|---|---|
Defining a Time Window for Neuroprotection and Glia Modulation by Caffeine After Neonatal Hypoxia-Ischaemia.
Topics: Animals; Brain Injuries; Caffeine; Demyelinating Diseases; DNA Fragmentation; Drug Administration Sc | 2020 |